Yern-Hyerk Shin

Dr. Yern-Hyerk Shin

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2025 in Journal of the American Chemical Society
Verified
Journal Article
Open access
YSYern-Hyerk Shin
Yern-Hyerk Shin
SBSunghee Bang
Sunghee Bang
RXRamnik Xavier
Ramnik Xavier
JCJon Clardy
Jon Clardy
Eggerthella lenta is both one of the most studied and least understood members of the human gut microbiome. Most of the interest in this Gram-positive anaerobe originates from multiple robust associations of its population with a variety of autoimmune diseases, perhaps most notably inflammatory bowel disease (IBD). The links between bacteria and inflammation are only partially known. Inflammation is driven by Th17 cells and their inflammatory cytokine IL-17, and the population of these cells is promoted by a transcription factor, RORγt. Bacterial metabolites appear to activate RORγt in a cell- and antigen-independent fashion, but the metabolites and their activating mechanism are unknown. This report describes an assay-driven search for pro-inflammatory metabolites from E. lenta that revealed a plasmalogen-triggered plasmalogen pair that forms a single molecule signal transduction device. Small electrophiles characteristic of inflammatory environments react with the plasmalogen's sensitive vinyl ether moiety to create a lipid signal, a lysoglycoglycerolipid that upregulates the inflammatory cytokines TNF-α and IL-6 through a TLR receptor. This provides a molecular mechanism that allows E. lenta to upregulate inflammatory responses in a cell- and antigen-independent fashion. This molecular mechanism is similar to an endogenous signaling system that upregulates RORγt through a triggered mammalian plasmalogen signal, 1-18:0-lysophosphatidylethanolamine.

16 January 2025 in Journal of the American Chemical Society
Verified
Journal Article
Open access
SBSunghee Bang
Sunghee Bang
YSYern-Hyerk Shin
Yern-Hyerk Shin
SPSung-Moo Park
Sung-Moo Park
Lei DengLei Deng
Lei Deng
RWR Thomas Williamson
R Thomas Williamson
JCJon Clardy
Jon Clardy
A multifactorial association study detected a probable causal connection between the prevalence of Morganella morganii in the gut microbiome and the incidence of major depressive disorder (MDD) in the human host. A bioassay-guided fractionation approach identified bacterially produced metabolites that induced pro-inflammatory immune responses. The metabolites are unusual phospholipids that resemble conventional cardiolipins, in which diethanolamine (DEA) replaces the central glycerol. These molecular chimeras of endogenous metabolites from phospholipid biosynthetic pathways and the industrially produced micropollutant DEA activate TLR2/TLR1 receptors and induce the production of pro-inflammatory cytokines, especially IL-6. Their activity in conventional immunomodulatory assays largely parallels that of immunogenic cardiolipins with conventional structures. The molecular mechanism connecting these chimeric cardiolipins to MDD is supported by other studies and has implications for conditions other than MDD.

18 July 2023 in Marine Drugs
Verified
Journal Article
Open access
PDF file
JIJi Hyeon Im
Ji Hyeon Im
YSYern-Hyerk Shin
Yern-Hyerk Shin
EBEun Seo Bae
Eun Seo Bae
SLSang Kook Lee
Sang Kook Lee
DODong-Chan Oh
Dong-Chan Oh
Four new chlorinated cycloaromatized enediyne compounds, jejucarbosides B–E (1–4), were discovered together with previously-identified jejucarboside A from a marine actinomycete strain. Compounds 1–4 were identified as new chlorinated cyclopenta[a]indene glycosides based on 1D and 2D nuclear magnetic resonance, high-resolution mass spectrometry, and circular dichroism (CD) spectra. Jejucarbosides B and E bear a carbonate functional group whereas jejucarbosides C and D are variants possessing 1,2-diol by losing the carbonate functionality. It is proposed that the production of 1–4 occurs via Bergman cycloaromatization capturing Cl- and H+ in the alternative positions of a p-benzyne intermediate derived from a 9-membered enediyne core. Jejucarboside E (4) displayed significant cytotoxicity against human cancer cell lines including SNU-638, SK-HEP-1, A549, HCT116, and MDA-MB-231, with IC50 values of 0.31, 0.40, 0.25, 0.29, and 0.48 μM, respectively, while jejucarbosides B–D (1–3) showed moderate or no cytotoxic effects.

15 April 2025 in Journal of the American Chemical Society
Verified
Journal Article
Open access
SBSunghee Bang
Sunghee Bang
YSYern-Hyerk Shin
Yern-Hyerk Shin
SPSung-Moo Park
Sung-Moo Park
Lei DengLei Deng
Lei Deng
RWR Thomas Williamson
R Thomas Williamson
JCJon Clardy
Jon Clardy

12 June 2026 in ACS Infectious Diseases
Verified
Journal Article
Closed access
GPGleb Pishchany
Gleb Pishchany
KFKyra E. Fryling
Kyra E. Fryling
VVVineetha Vasukuttan
Vineetha Vasukuttan
YSYern-Hyerk Shin
Yern-Hyerk Shin
TMTatum D. Mortimer
Tatum D. Mortimer
JCJon Clardy
Jon Clardy

25 October 2025 in Applied Sciences
Verified
Journal Article
Open access
PDF file
RDRobel Demissie
Robel Demissie
TVTasneem Vaid
Tasneem Vaid
YKYoungjin Kwon
Youngjin Kwon
GSgauri shetye
gauri shetye
TTThao Tran
Thao Tran
HLHyun Lee
Hyun Lee
Drug-resistant Mycobacterium tuberculosis (Mtb) remains a major global health challenge, prompting the need for new therapeutics targeting essential bacterial proteins. The caseinolytic protein C1 (ClpC1) is a promising drug target, and accurate measurement of its ATPase activity is critical for understanding drug mechanisms. We optimized a sensitive luminescence-based ATPase assay and evaluated ClpC1 constructs with various tag positions and truncations. N-terminal tagging significantly impaired enzymatic activity, whereas C-terminal tagging had no effect; truncated domains showed reduced activity compared to native full-length (FL) ClpC1. Using the native FL-ClpC1, we assessed ecumicin (ECU) and five analogs via ATPase activity and surface plasmon resonance (SPR), using rufomycin (RUF) and cyclomarin A (CYMA) as controls. RUF and CYMA bound tightly (KD = 0.006–0.023 µM) and inhibited Mtb growth (MIC90 = 0.02–0.094 µM) but modestly stimulated ATPase activity (≤2-fold). In contrast, ECU and its analogs strongly enhanced ATPase activity (4–9-fold) despite slightly weaker binding (KD = 0.042–0.80 µM) and growth inhibition (MIC90 = 0.19 µM). The partial correlation among AC50, KD, and MIC values highlights the complementary value of enzymatic, biophysical, and cellular assays. Our assay platform enables mechanistic characterization of ClpC1-targeting compounds and supports rational antitubercular drug development.